RecruitingNot applicableNCT05577819
Rare condition
Hereditary ATTR amyloidosis
46
studies recruiting now
as of 7 Sept 2026
186
studies registered in total
as of 7 Sept 2026
7
countries with a recruiting site
as of 7 Sept 2026
3 Oct 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT05489549
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
RecruitingNCT07205666
The Eplontersen Pregnancy and Lactation Outcomes Study
RecruitingNot applicableNCT04849754
Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy
RecruitingNCT06465810
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 46 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Hereditary ATTR amyloidosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Hereditary ATTR amyloidosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
1 approved treatment, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Patisiran
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).